Inactive Instrument

Calendar A.P. Pharma, Inc. OTC Bulletin Board

Equities

APPA

US00202J2033

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for A.P. Pharma, Inc.

Chart calendar A.P. Pharma, Inc.

92c3fe60b38b45b078ff5da526598af.nu2pv2651N8GMaaA0zCA1ElC88PvM0-R6XeH4WyPCvo.94_IjCXjjoU_HNX0sQjP5ycbwPPaCnqm3xzQpz_8bL-zgsrcC-uymEJi8w~f2e5943678aecbead0a62995bc362db7

Upcoming events on A.P. Pharma, Inc.

2024-08-04 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)
2025-02-19 Q4 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)

Past events on A.P. Pharma, Inc.

2024-06-13 09:00 am Annual General Meeting
2024-05-15 09:30 am Investor Day
2024-05-07 08:30 am Q1 2024 Earnings Call
2024-05-07 08:00 am Q1 2024 Earnings Release
2024-04-10 11:00 am Needham Healthcare Conference
2024-03-12 04:30 pm Q4 2023 Earnings Call
2024-03-12 04:05 pm Q4 2023 Earnings Release
2023-11-14 04:30 pm Q3 2023 Earnings Call
2023-11-14 04:05 pm Q3 2023 Earnings Release
2023-09-18 Northland Capital Markets Institutional Investor Conference
2023-08-14 04:30 pm Q2 2023 Earnings Call
2023-08-14 04:05 pm Q2 2023 Earnings Release
2023-06-07 Annual General Meeting
2023-05-11 04:30 pm Q1 2023 Earnings Call
2023-05-11 04:01 pm Q1 2023 Earnings Release
2023-04-20 11:45 am Needham Healthcare Conference
2023-03-23 04:30 pm Q4 2022 Earnings Call
2023-03-23 04:05 pm Q4 2022 Earnings Release
2023-03-07 02:10 pm Cowen Health Care Conference
2022-12-01 10:05 am Evercore ISI HealthCONX Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
146
142
2.84%
88,6
87,4
1.41%
86,3
91,8
-5.98%
108
105
2.63%
127
124
2.8%

148

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
-225
-177
-27.3%
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-211
-202
-4.2%
-228
-220
-3.56%
-218
-223
2.12%
-175
-191
8.77%
-111
-124
10.97%

-15,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-205
-197
-4.12%
-227
-224
-1.41%
-221
-225
1.82%
-182
-197
7.6%
-111
-124
11%

-14,3

Net income
Million USD
Released
Forecast
Spread
-205
-198
-3.67%
-227
-224
-1.41%
-221
-225
1.82%
-182
-197
7.6%
-111
-121
8.42%

-14,3

EPS
USD
Released
Forecast
Spread
-2,50
-2,40
-4.34%
-2,50
-2,47
-1.33%
-2,24
-2,28
1.9%
-1,67
-1,85
9.63%
-0,80
-0,93
13.67%

-0,09

Announcement Date02/03/2024/02/2128/02/2223/03/2312/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
23,5
22,6
3.76%
27,6
24,7
12.08%
26,6
27,0
-1.49%
30,0
27,2
10.24%
29,6
29,7
-0.24%
31,8
31,7
0.21%
31,4
31,8
-1.25%
34,2
31,2
9.66%
34,7
33,0
5.14%

35,9


36,9


40,4

EBIT
Million USD
Released
Forecast
Spread
-62,9
-48,4
-30.11%
-49,5
-51,1
3.19%
-41,9
-42,1
0.46%
-20,4
-37,1
45.21%
-33,1
-23,7
-39.77%
-42,4
-27,8
-52.65%
-24,9
-38,2
34.73%
-10,2
-23,4
56.36%
-4,80
-10,9
55.85%

-5,24


-4,00


-1,37

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-63,9
-48,8
-30.96%
-56,4
-52,4
-7.6%
-41,9
-44,1
5%
-19,9
-36,1
45.03%
-32,8
-24,0
-36.29%
-42,1
-28,3
-48.76%
-25,0
-38,0
34.13%
-10,7
-24,0
55.29%
-3,16
-10,7
70.36%

-5,30


-3,90


-1,50

Net income
Million USD
Released
Forecast
Spread
-63,9
-48,8
-30.96%
-56,4
-52,4
-7.6%
-41,9
-44,1
5%
-19,9
-36,1
45.03%
-32,8
-24,0
-36.29%
-42,1
-28,3
-48.76%
-25,0
-38,0
34.13%
-10,7
-24,0
55.29%
-3,16
-10,7
70.36%

-5,30


-3,90


-1,50

EPS
USD
Released
Forecast
Spread
-0,63
-0,48
-32.35%
-0,55
-0,50
-9.13%
-0,38
-0,38
-1.06%
-0,17
-0,32
46.2%
-0,27
-0,20
-33.33%
-0,35
-0,23
-49.57%
-0,17
-0,31
45.74%
-0,07
-0,16
57.14%
-0,02
-0,07
71.43%

-0,04


-0,03


-0,01

Announcement Date09/05/2209/08/2208/11/2223/03/2311/05/2314/08/2314/11/2312/03/2407/05/24---